DK1624869T3 - Doseringsform indeholdende pantoprazol som aktiv bestanddel - Google Patents

Doseringsform indeholdende pantoprazol som aktiv bestanddel

Info

Publication number: DK1624869T3
Authority: DK; Denmark
Prior art keywords: pantoprazol; active ingredient; dosage form; form containing; dosage
Prior art date: 2003-05-08

Application number

DK04741525.2T

Other languages

English (en)

Inventor

Isabel Anstett-Klein

Marc Schiller

Sabine Schaefer-Preuss

Rango Dietrich

Hartmut Ney

Manfred Hartmann

Original Assignee

Nycomed Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-08

Filing date

2004-05-07

Publication date

2012-10-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33436112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1624869(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-05-07 Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh

2012-10-01 Application granted granted Critical

2012-10-01 Publication of DK1624869T3 publication Critical patent/DK1624869T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK04741525.2T 2003-05-08 2004-05-07 Doseringsform indeholdende pantoprazol som aktiv bestanddel DK1624869T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03010328		2003-05-08
EP04001754		2004-01-28
PCT/EP2004/050729 WO2004098594A2 (en)	2003-05-08	2004-05-07	Dosage form containing pantoprazole as active ingredient

Publications (1)

Publication Number	Publication Date
DK1624869T3 true DK1624869T3 (da)	2012-10-01

Family

ID=33436112

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK10175417.4T DK2316454T3 (da)	2003-05-08	2004-05-07	Doseringsform indeholdende pantoprazol som aktiv bestanddel
DK04741525.2T DK1624869T3 (da)	2003-05-08	2004-05-07	Doseringsform indeholdende pantoprazol som aktiv bestanddel

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK10175417.4T DK2316454T3 (da)	2003-05-08	2004-05-07	Doseringsform indeholdende pantoprazol som aktiv bestanddel

Country Status (27)

Country	Link
US (2)	US20060240100A1 (da)
EP (2)	EP2316454B9 (da)
JP (2)	JP4878284B2 (da)
KR (2)	KR20110104124A (da)
AR (1)	AR044264A1 (da)
AU (2)	AU2004237363B2 (da)
BR (2)	BR122016006880B8 (da)
CA (1)	CA2489140C (da)
CL (1)	CL2004000983A1 (da)
CY (2)	CY1113128T1 (da)
DK (2)	DK2316454T3 (da)
EA (2)	EA016824B1 (da)
ES (2)	ES2390342T3 (da)
HK (1)	HK1090546A1 (da)
HR (2)	HRP20120754T1 (da)
IL (2)	IL171365A (da)
MX (1)	MXPA05000411A (da)
NO (1)	NO337921B1 (da)
NZ (1)	NZ543181A (da)
PE (1)	PE20050199A1 (da)
PL (2)	PL1624869T3 (da)
PT (2)	PT2316454E (da)
RS (1)	RS53443B (da)
SI (2)	SI1624869T1 (da)
TW (1)	TW200509992A (da)
WO (1)	WO2004098594A2 (da)
ZA (1)	ZA200508202B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20050150A1 (es)	2003-05-08	2005-03-22	Altana Pharma Ag	Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en) *	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
JP2007536349A (ja)	2004-05-07	2007-12-13	ニコメッドゲゼルシャフトミットベシュレンクテルハフツング	新規の医薬剤形及び製造方法
EP1895990A2 (en) *	2005-05-13	2008-03-12	Combino Pharm, S.L.	Formulations containing pantoprazole free acid and its salts
EP1747776A1 (en) *	2005-07-29	2007-01-31	KRKA, tovarna zdravil, d.d., Novo mesto	Pharmaceutical composition comprising granular pantoprazole
TWI519322B (zh) *	2008-04-15	2016-02-01	愛戴爾製藥股份有限公司	包含弱鹼性藥物及控制釋放劑型之組合物
WO2010018593A2 (en) *	2008-07-03	2010-02-18	Torrent Pharmaceuticals Ltd.	Gastric acid resistant benzimidazole multiple unit tablet composition
JP2013531059A (ja) *	2010-07-22	2013-08-01	ルピン・リミテッド	マルチユニット錠剤組成物
KR101787481B1 (ko)	2010-10-21	2017-10-18	롯데정밀화학 주식회사	장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
ITMI20111168A1 (it) *	2011-06-27	2012-12-28	Professional Dietetics Srl	Composizioni farmaceutiche comprendenti idrossipropilmetilcellulosa e/o acido ialuronico e loro uso
JP2015522653A (ja) *	2012-07-26	2015-08-06	ルピン・リミテッドＬｕｐｉｎＬｉｍｉｔｅｄ	プロトンポンプ阻害剤の医薬組成物
WO2016174664A1 (en)	2015-04-29	2016-11-03	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
IN201611034271A (de) *	2016-10-06	2018-04-13		Delayed Release Pharmaceutical Composition Of Pantoprazole And Process For Preparation Thereof
US12102624B2 (en)	2020-08-26	2024-10-01	Nivagen Pharmaceuticals, Inc.	Pantoprazole compositions and methods
WO2023214016A1 (en) *	2022-05-06	2023-11-09	Evonik Operations Gmbh	Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv)	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
IL75400A (en)	1984-06-16	1988-10-31	Byk Gulden Lomberg Chem Fab	Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja)	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
GB2189699A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated acid-labile medicaments
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
FI90544C (fi)	1986-11-13	1994-02-25	Eisai Co Ltd	Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US5026560A (en)	1987-01-29	1991-06-25	Takeda Chemical Industries, Ltd.	Spherical granules having core and their production
IL85472A (en)	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
JPH0768125B2 (ja)	1988-05-18	1995-07-26	エーザイ株式会社	酸不安定化合物の内服用製剤
DE3901151A1 (de)	1989-01-17	1990-07-19	Hoechst Ag	Stabile pharmazeutische zubereitungen von thienoimidazol-derivaten und deren orale anwendung als magensaeuresekretionshemmer
DE69101291T2 (de) *	1990-08-30	1994-07-07	Senju Pharma Co	Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
YU48263B (sh)	1991-06-17	1997-09-30	Byk Gulden Lomberg Chemische Fabrik Gmbh.	Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
JP3722293B2 (ja) *	1991-12-18	2005-11-30	ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー	新規な薬学的固体分散物
EP0695123A4 (en) *	1993-04-27	1996-09-11	Sepracor Inc	METHOD AND COMPOSITIONS FOR TREATING GASTRICAL FAULTS USING OPTICALLY PURE PANTOPRAZOLS
SI0723436T1 (en)	1994-07-08	2002-02-28	Astrazeneca Ab	Multiple unit tableted dosage form i
SE9402431D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
US5945124A (en)	1995-07-05	1999-08-31	Byk Gulden Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) *	1995-07-05	2000-10-17	Byk Gulden Lomberg Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
SE9600070D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
SE512835C2 (sv) *	1996-01-08	2000-05-22	Astrazeneca Ab	Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE508669C2 (sv)	1996-04-26	1998-10-26	Astra Ab	Nytt förfarande
JP3249914B2 (ja)	1996-06-04	2002-01-28	清水食品株式会社	成型用焼結金型およびその形成方法
US6072024A (en)	1997-03-21	2000-06-06	Mitsui Chemicals, Inc.	Production process of cross-linked polyaspartic acid resin
AU1671799A (en) *	1997-11-28	1999-06-16	Byk Gulden Lomberg Chemische Fabrik Gmbh	Medicament preparation in the form of a tablet or pellet for acid-labile active substances
ES2216351T3 (es)	1997-12-08	2004-10-16	Altana Pharma Ag	Nueva forma de supositorio que comprende un compuesto activo labil o acidos.
SE9704869D0 (sv) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulaton II
PL205145B1 (pl) *	1998-05-15	2010-03-31	Warner Lambert Co	Trwała kompozycja stała zawierająca pochodną 4-amino-3-podstawionego kwasu butanowego oraz sposób jej wytwarzania
ZA9810765B (en) *	1998-05-28	1999-08-06	Ranbaxy Lab Ltd	Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
JP3274416B2 (ja) *	1998-05-29	2002-04-15	佐藤製薬株式会社	口腔内崩壊性粒状製剤
ATE321538T1 (de)	1998-08-12	2006-04-15	Altana Pharma Ag	Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
DE19843413C1 (de)	1998-08-18	2000-03-30	Byk Gulden Lomberg Chem Fab	Neue Salzform von Pantoprazol
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
BR0011347A (pt)	1999-06-07	2002-03-19	Byk Gulden Lomberg Chem Fab	Preparações e formas de administração compreendendo um composto ativo de ácido instável
US6420473B1 (en) *	2000-02-10	2002-07-16	Bpsi Holdings, Inc.	Acrylic enteric coating compositions
US6346269B1 (en) *	2000-05-08	2002-02-12	Standard Chem. & Pharm. Co., Ltd.	Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
SI20720A (sl) *	2000-11-20	2002-06-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
MY137726A (en) *	2000-11-22	2009-03-31	Nycomed Gmbh	Freeze-dried pantoprazole preparation and pantoprazole injection
CA2430824C (en) *	2000-12-07	2012-05-08	Altana Pharma Ag	Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
ATE541564T1 (de)	2000-12-07	2012-02-15	Nycomed Gmbh	Schnell zerfallende tablette mit einem säurelabilen wirkstoff
MY140561A (en) *	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
PE20050150A1 (es)	2003-05-08	2005-03-22	Altana Pharma Ag	Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en)	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
JP2007536349A (ja)	2004-05-07	2007-12-13	ニコメッドゲゼルシャフトミットベシュレンクテルハフツング	新規の医薬剤形及び製造方法
JP4563077B2 (ja)	2004-05-28	2010-10-13	株式会社ロッテ	キャンディ及びその製造方法

2004
- 2004-05-04 CL CL200400983A patent/CL2004000983A1/es unknown
- 2004-05-05 PE PE2004000457A patent/PE20050199A1/es not_active Application Discontinuation
- 2004-05-07 PL PL04741525T patent/PL1624869T3/pl unknown
- 2004-05-07 SI SI200431922T patent/SI1624869T1/sl unknown
- 2004-05-07 AR ARP040101558A patent/AR044264A1/es not_active Application Discontinuation
- 2004-05-07 PT PT101754174T patent/PT2316454E/pt unknown
- 2004-05-07 EA EA200501697A patent/EA016824B1/ru not_active IP Right Cessation
- 2004-05-07 WO PCT/EP2004/050729 patent/WO2004098594A2/en active Application Filing
- 2004-05-07 ES ES04741525T patent/ES2390342T3/es not_active Expired - Lifetime
- 2004-05-07 AU AU2004237363A patent/AU2004237363B2/en not_active Ceased
- 2004-05-07 MX MXPA05000411A patent/MXPA05000411A/es active IP Right Grant
- 2004-05-07 RS YU20050818A patent/RS53443B/en unknown
- 2004-05-07 NZ NZ543181A patent/NZ543181A/en not_active IP Right Cessation
- 2004-05-07 DK DK10175417.4T patent/DK2316454T3/da active
- 2004-05-07 PL PL10175417T patent/PL2316454T3/pl unknown
- 2004-05-07 SI SI200431976T patent/SI2316454T1/sl unknown
- 2004-05-07 ES ES10175417T patent/ES2396197T3/es not_active Expired - Lifetime
- 2004-05-07 BR BR122016006880A patent/BR122016006880B8/pt active IP Right Grant
- 2004-05-07 DK DK04741525.2T patent/DK1624869T3/da active
- 2004-05-07 BR BRPI0410044A patent/BRPI0410044B8/pt active IP Right Grant
- 2004-05-07 EP EP10175417A patent/EP2316454B9/en not_active Expired - Lifetime
- 2004-05-07 JP JP2006505591A patent/JP4878284B2/ja not_active Expired - Fee Related
- 2004-05-07 CA CA002489140A patent/CA2489140C/en not_active Expired - Lifetime
- 2004-05-07 PT PT04741525T patent/PT1624869E/pt unknown
- 2004-05-07 US US10/555,238 patent/US20060240100A1/en not_active Abandoned
- 2004-05-07 EA EA201101119A patent/EA027734B1/ru not_active IP Right Cessation
- 2004-05-07 KR KR1020117019680A patent/KR20110104124A/ko not_active Application Discontinuation
- 2004-05-07 TW TW093113016A patent/TW200509992A/zh unknown
- 2004-05-07 EP EP04741525A patent/EP1624869B1/en not_active Expired - Lifetime
- 2004-05-07 KR KR1020057020740A patent/KR101237742B1/ko active IP Right Grant
2005
- 2005-10-11 IL IL171365A patent/IL171365A/en active IP Right Grant
- 2005-10-11 ZA ZA2005/08202A patent/ZA200508202B/en unknown
- 2005-11-29 NO NO20055631A patent/NO337921B1/no not_active IP Right Cessation
2006
- 2006-10-11 HK HK06111165.0A patent/HK1090546A1/xx not_active IP Right Cessation
2009
- 2009-04-03 US US12/385,280 patent/US8703192B2/en not_active Expired - Fee Related
2010
- 2010-03-10 AU AU2010200905A patent/AU2010200905B2/en not_active Ceased
2011
- 2011-03-16 JP JP2011057961A patent/JP5162689B2/ja not_active Expired - Fee Related
2012
- 2012-09-19 CY CY20121100860T patent/CY1113128T1/el unknown
- 2012-09-24 HR HRP20120754TT patent/HRP20120754T1/hr unknown
- 2012-12-06 HR HRP20121005TT patent/HRP20121005T1/hr unknown
- 2012-12-12 CY CY20121101214T patent/CY1113462T1/el unknown
2013
- 2013-11-20 IL IL229510A patent/IL229510A/en active IP Right Grant

Also Published As

Publication number	Publication date
BR122016006880B1 (pt)	2020-11-10
EP1624869B1 (en)	2012-07-04
WO2004098594A2 (en)	2004-11-18
NZ543181A (en)	2009-10-30
KR20110104124A (ko)	2011-09-21
BRPI0410044B8 (pt)	2021-05-25
ES2396197T3 (es)	2013-02-19
JP5162689B2 (ja)	2013-03-13
US8703192B2 (en)	2014-04-22
RS20050818A (en)	2008-04-04
PL1624869T3 (pl)	2012-11-30
WO2004098594A3 (en)	2004-12-09
CA2489140C (en)	2006-10-17
EP2316454B9 (en)	2013-01-02
AU2004237363B2 (en)	2009-12-10
RS53443B (en)	2014-12-31
ES2390342T3 (es)	2012-11-12
IL171365A (en)	2014-08-31
US20060240100A1 (en)	2006-10-26
SI2316454T1 (sl)	2013-01-31
JP4878284B2 (ja)	2012-02-15
EP2316454A1 (en)	2011-05-04
EA016824B1 (ru)	2012-07-30
BR122016006880B8 (pt)	2021-05-25
EP2316454B1 (en)	2012-09-26
CY1113128T1 (el)	2016-04-13
NO337921B1 (no)	2016-07-11
PT1624869E (pt)	2012-09-18
JP2011126912A (ja)	2011-06-30
IL229510A0 (en)	2013-12-31
SI1624869T1 (sl)	2012-10-30
BRPI0410044A (pt)	2006-04-25
IL229510A (en)	2016-09-29
EP1624869A2 (en)	2006-02-15
JP2006525286A (ja)	2006-11-09
MXPA05000411A (es)	2005-03-23
HRP20121005T1 (hr)	2013-01-31
HRP20120754T1 (hr)	2012-11-30
PT2316454E (pt)	2012-12-06
TW200509992A (en)	2005-03-16
EA200501697A1 (ru)	2006-06-30
AU2010200905B2 (en)	2012-04-05
KR20060010774A (ko)	2006-02-02
PL2316454T3 (pl)	2013-03-29
AR044264A1 (es)	2005-09-07
AU2010200905A1 (en)	2010-04-01
NO20055631L (no)	2005-11-29
EA027734B1 (ru)	2017-08-31
DK2316454T3 (da)	2013-01-21
HK1090546A1 (en)	2006-12-29
AU2004237363A1 (en)	2004-11-18
CY1113462T1 (el)	2016-06-22
EA201101119A1 (ru)	2011-12-30
KR101237742B1 (ko)	2013-02-26
BRPI0410044B1 (pt)	2019-05-07
US20090208571A1 (en)	2009-08-20
PE20050199A1 (es)	2005-03-26
CA2489140A1 (en)	2004-11-18
CL2004000983A1 (es)	2005-03-04
ZA200508202B (en)	2006-12-27

Publication	Publication Date	Title
NO20042807L (no)	2004-07-02	Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
NO20043702L (no)	2004-12-03	8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
DK1660104T3 (da)	2010-06-21	Farmaceutisk formulering indeholdende lanthanforbindelser
FR15C0095I2 (fr)	2016-07-01	Combinaisons synergiques de substances actives fongicides
DK1498411T3 (da)	2013-04-15	Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
DK1592457T3 (da)	2012-10-22	Folat-vinblastin-konjugat som lægemiddel
NO20050426L (no)	2005-03-29	Arylkarbonylderivater som terapeutiske midler
IL229510A0 (en)	2013-12-31	A dosage form containing pantoprazole as an active ingredient
NO20055143D0 (no)	2005-11-02	Doseringsformer innbefattende AG013736
EP1631239A4 (en)	2008-03-05	PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D
DE60317967D1 (de)	2008-01-24	Umhüllte feste Darreichungsform
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
NO20052739D0 (no)	2005-06-07	CCR5-antagonister som medikamenter
NO20052952D0 (no)	2005-06-16	Farmasoytisk sammensetning som innbefatter mikropartikler
DK1864665T3 (da)	2012-07-23	Immunsuppressivt middel indeholdende en heterocyklisk forbindelse som aktiv bestanddel
ATE394928T1 (de)	2008-05-15	Synergistische insektizide mischungen
ATE427658T1 (de)	2009-04-15	Synergistische insektizide mischungen
DK1608362T3 (da)	2007-05-14	Stabiliseret farmaceutisk præparat indeholdende en amorf aktiv forbindelse
DK1932522T3 (da)	2012-07-02	Terapeutisk middel mod leversygdom indeholdende 2-amino-1,3-propandiolderivat som aktiv bestanddel
DK1557415T3 (da)	2012-09-17	Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
NO20054214D0 (no)	2005-09-12	Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
DK1705989T3 (da)	2009-01-19	Substituerede arylpyrazoler som parasiticide midler
ATE369139T1 (de)	2007-08-15	Hochdosierte ibandronat-formulierung
NO20032614L (no)	2003-08-05	Farmasöytisk sammensetning som har forbedret absorberbarhet
DK1666473T3 (da)	2013-03-25	Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens